The MaineHealth hypertrophic cardiomyopathy program supports your heart health with expert, guideline-driven care based on the newest science-based tools and techniques.
Our multidisciplinary team combines skill and experience in cardiology, electrophysiology, cardiac surgery, imaging, pharmacy and nursing.
What is Hypertrophic Cardiomyopathy?
Hypertrophic cardiomyopathy (HCM) is a type of heart disease that affects the heart muscle and can lead to irregular heart rhythms and heart failure. Our specialists treat patients in which the heart’s ventricular walls have become excessively thick, making it difficult for the heart to pump out blood.
Symptoms can include shortness of breath, chest pain, palpitations, fainting, and—less commonly—sudden cardiac death. Hypertrophic cardiomyopathy (HCM) is the most common genetic heart condition.
Services:
- Imaging and diagnostics
Echocardiogram & stress echocardiogram (HCM protocols), cardiac MRI, cardiac CT/CTA, nuclear imaging and CPET - Electrophysiology
Ablation for AFib/AFlutter/SVT/VT; transvenous & leadless pacemakers; transvenous & subcutaneous ICDs; loop recorders - Myosin Inhibitor Clinic
Structured Camzyos® program with same‑day echocardiogram, REMS compliance, pharmacy coordination and close follow‑up - Women’s Heart Health
Cardio‑obstetrics and risk management across the lifespan in collaboration with MaineHealth Women’s Heart Health - Behavioral Health
Integrated behavioral health providers for counseling and coping strategies—available in person and via telehealth - Sports Cardiology
Participation guidance and community screening for competitive athletes and active individuals - Advanced Heart Failure
Heart failure and mechanical circulatory support, and cardiac transplant coordination when needed - Cardiac Rehabilitation
Cardiac rehab and exercise programs tailored to HCM patients
